Ann: New Clinical Advisory Board for PromarkerD global rollout, page-8

l misread the crux of the announcement. Advisory Board is a good idea for sure but it is not a marketing/ advertising push. l think getting word out there in prescriber land and large volumes of sales is a long way off. No one l have spoken to has even heard of PIQ, let alone a Pro Marker D test. Short of running advertisements on prime time media slots, l think the conventional medical way is going to be ultra slow and ultra conservative. Just like the medical fraternity always has been. How many years until this company is cash flow positive? Any guesses? Probably impossible to answer because it depends on too many potential variables. The American Medicare rebate code will be a huge milestone and confidence builder in consumer land simple because it will give a legitimacy to the Company that it will benefit from. Lots of valid reasons why it has not been granted to date, but they are less valid now as things return to normal. A back load of applications possibly, but given PIQ submitted their application some time ago, one has to think news on that front is imminent. Endometriosis results later this year should also value add, so l hope the SP steadily grows on our latent value even if sales lagg in the short term.